Royalty Pharma plc (RPRX) NASDAQ
50.79
+0.59(+1.18%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
50.79
+0.59(+1.18%)
Currency In USD
| Market Cap | 16.69B |
| Enterprise Value | 25.02B |
| P/E Ratio | 26.33 |
| PEG Ratio | -0.94 |
| Price/Sales Ratio | 8.91 |
| Price/Book Ratio | 2.19 |
| Enterprise/Revenue | 12.34 |
| Enterprise/EBITDA | 17.74 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 0.34 |
| Operating Margin | 0.65 |
| Return On Assets | 0.04 |
| Return On Equity | 0.11 |
| Revenue | 2.38B |
| Revenue/Share | 5.69 |
| Gross Profit | 2.38B |
| EBITDA | 1.64B |
| Net Income | 770.95M |
| Diluted EPS | 1.8 |
| Total Cash | 608.29M |
| Total Cash/Share | 1.42 |
| Total Debt | 8.96B |
| Total Debt/Equity | 0.9 |
| Current Ratio | 1.09 |
| Book Value Per Share | 23.16 |
| 52-Week Change | 53.44 |
| 52-Week High | 51.65 |
| 52-Week Low | 32.15 |
| Moving Average 50 Days | 47.74 |
| Moving Average 200 Days | 40.84 |
| Average Volume | 3.37M |
| Shares Outstanding | 428.42M |
| % Held by Institutions | 83.03 |
| Trailing Annual Dividend Rate | 0.89 |
| Trailing Annual Dividend Yield | 1.76 |
| Payout Ratio | 0.47 |
| Last Split Factor | N/A |
| Last Split Date | N/A |